LIPO Stock Summary and Trading Ideas (Lipella Pharmaceuticals | NASDAQ:LIPO)

Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.

Lipella Pharmaceuticals trades on the NASDAQ stock market under the symbol LIPO.

As of April 3, 2025, LIPO stock price declined to $2.50 with 19,849 million shares trading.

LIPO has a beta of 0.23, meaning it tends to be less sensitive to market movements. LIPO has a correlation of 0.00 to the broad based SPY ETF.

LIPO has a market cap of $6.37 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that LIPO belongs to (by Net Assets): VXF.

LIPO has underperformed the market in the last year with a return of -55.4%, while the SPY ETF gained +4.8%. In the last 3 month period, LIPO fell short of the market, returning -21.4%, while SPY returned -7.9%. However, in the most recent 2 weeks LIPO has outperformed the stock market by returning +5.9%, while SPY returned -5.1%.

LIPO support price is $2.39 and resistance is $2.77 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LIPO shares will trade within this expected range on the day.